The human Müllerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer. Validation using the mAb 12G4.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Thierry Chardès Caroline Bascoul-Mollevi Isabelle Navarro-Teulon Imed Salhi |
| Publication date | January 1, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |